Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals
NR 565 Advanced Pharmacology Fundamentals
Final Comprehensive Examination 2026/2027 |
Verified Questions
Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals | University-Level
Advanced Practice Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals
Final Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 565 Advanced Pharmacology Fundamentals Final Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This Final Comprehensive Examination contains exactly 100 original verified questions designed to
reinforce the official Chamberlain College of Nursing NR 565 Advanced Pharmacology Fundamentals
course objectives for actual exam readiness and clinical proficiency, aligned to the 2026/2027 academic
year. The questions are organized across four core domains: Domain 1 – Pharmacologic Principles and
Pharmacokinetics (25 questions); Domain 2 – Cardiovascular and Respiratory Pharmacology (25
questions); Domain 3 – Neurological, Psychiatric, and Pain Management Pharmacology (25 questions);
and Domain 4 – Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25 questions). Each
question is accompanied by the correct answer and a detailed rationale grounded in foundational
advanced pharmacology methodology, including principles drawn from university-level advanced nursing
curricula and established textbooks such as Rosenthal’s Nurse Prescribing Pharmacology and Lehne’s
Pharmacology for Advanced Practice Nursing. The content emphasizes accurate application of
pharmacokinetic principles, safe prescribing of cardiovascular, respiratory, neurologic, psychiatric,
endocrine, gastrointestinal, and musculoskeletal agents, and recognition of clinically significant drug
interactions and monitoring parameters.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles and Pharmacokinetics
Question 1. Which process describes the movement of a drug from its site of
administration into the systemic circulation?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A
Rationale: Absorption is the transfer of drug from the administration site into the bloodstream.
Distribution, metabolism, and excretion occur after the drug has entered the systemic circulation.
Question 2. A drug with a high first-pass effect is most appropriately administered by
which route to achieve therapeutic plasma levels?
A. Oral tablet only
B. Sublingual administration is always inferior
C. Intravenous or another parenteral route that bypasses the liver
D. Rectal administration has higher first-pass than oral
Correct Answer: C
Rationale: High first-pass metabolism extensively reduces oral bioavailability. Parenteral routes (IV,
IM, SQ) or routes that largely avoid portal circulation (e.g., sublingual, transdermal) circumvent first-
pass hepatic metabolism.
Question 3. The volume of distribution (Vd) of a drug is best described as:
A. The apparent volume into which the drug is distributed, calculated as amount of drug in body
divided by plasma concentration
B. The actual anatomic volume of plasma only
C. The rate of renal clearance
D. The fraction of drug bound to plasma proteins
Correct Answer: A
Rationale: Vd = Amount of drug in body / Plasma concentration. It is a theoretical volume that
indicates the extent of tissue distribution; a large Vd implies extensive tissue binding.
NR 565 Advanced Pharmacology Fundamentals Final Comprehensive Examination 2026/2027 | Verified Questions
, Question 4. Which pharmacokinetic parameter is most useful for determining the dosing
interval of a drug?
A. Volume of distribution alone
B. Elimination half-life (t½)
C. Bioavailability only
D. Protein-binding percentage
Correct Answer: B
Rationale: Half-life determines how quickly plasma concentration declines and therefore guides dosing
frequency. Drugs with short half-lives generally require more frequent dosing or continuous infusion.
Question 5. A drug that is a strong CYP3A4 inducer will most likely have which effect on a
co-administered CYP3A4 substrate?
A. Increase the plasma concentration of the substrate
B. Have no effect on the substrate
C. Decrease the plasma concentration of the substrate, potentially reducing its efficacy
D. Only affect renal excretion of the substrate
Correct Answer: C
Rationale: CYP inducers increase the synthesis of metabolizing enzymes, accelerating clearance of
substrates and lowering their plasma levels. Dose adjustments or alternative agents may be required.
Question 6. Zero-order elimination kinetics means that:
A. A constant amount of drug is eliminated per unit time, independent of plasma concentration
B. A constant fraction of drug is eliminated per unit time
C. Elimination rate increases linearly with concentration
D. The drug is eliminated only by the kidneys
Correct Answer: A
Rationale: In zero-order kinetics (e.g., high-dose phenytoin, ethanol), elimination pathways are
saturated, so a fixed amount is removed per time. Most drugs at therapeutic doses follow first-order
kinetics.
Question 7. Which statement about protein binding is correct?
A. Bound drug is the only active form
B. Protein binding increases the free fraction
C. Highly protein-bound drugs are always short-acting
D. Only the unbound (free) fraction of a drug is pharmacologically active and available for metabolism
and excretion
Correct Answer: D
Rationale: The free fraction interacts with receptors and is subject to clearance. Highly protein-bound
drugs can be displaced by other highly bound drugs, transiently increasing free concentration.
Question 8. Bioavailability (F) of an orally administered drug is defined as:
A. The total amount of drug excreted in urine
B. The rate of absorption only
C. The fraction of the administered dose that reaches the systemic circulation unchanged
D. The volume of distribution
Correct Answer: C
Rationale: Bioavailability accounts for both the extent of absorption and the degree of first-pass
metabolism. IV administration is defined as having F = 1.
NR 565 Advanced Pharmacology Fundamentals Final Comprehensive Examination 2026/2027 | Verified Questions
NR 565 Advanced Pharmacology Fundamentals
Final Comprehensive Examination 2026/2027 |
Verified Questions
Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals | University-Level
Advanced Practice Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals
Final Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 565 Advanced Pharmacology Fundamentals Final Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This Final Comprehensive Examination contains exactly 100 original verified questions designed to
reinforce the official Chamberlain College of Nursing NR 565 Advanced Pharmacology Fundamentals
course objectives for actual exam readiness and clinical proficiency, aligned to the 2026/2027 academic
year. The questions are organized across four core domains: Domain 1 – Pharmacologic Principles and
Pharmacokinetics (25 questions); Domain 2 – Cardiovascular and Respiratory Pharmacology (25
questions); Domain 3 – Neurological, Psychiatric, and Pain Management Pharmacology (25 questions);
and Domain 4 – Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25 questions). Each
question is accompanied by the correct answer and a detailed rationale grounded in foundational
advanced pharmacology methodology, including principles drawn from university-level advanced nursing
curricula and established textbooks such as Rosenthal’s Nurse Prescribing Pharmacology and Lehne’s
Pharmacology for Advanced Practice Nursing. The content emphasizes accurate application of
pharmacokinetic principles, safe prescribing of cardiovascular, respiratory, neurologic, psychiatric,
endocrine, gastrointestinal, and musculoskeletal agents, and recognition of clinically significant drug
interactions and monitoring parameters.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles and Pharmacokinetics
Question 1. Which process describes the movement of a drug from its site of
administration into the systemic circulation?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A
Rationale: Absorption is the transfer of drug from the administration site into the bloodstream.
Distribution, metabolism, and excretion occur after the drug has entered the systemic circulation.
Question 2. A drug with a high first-pass effect is most appropriately administered by
which route to achieve therapeutic plasma levels?
A. Oral tablet only
B. Sublingual administration is always inferior
C. Intravenous or another parenteral route that bypasses the liver
D. Rectal administration has higher first-pass than oral
Correct Answer: C
Rationale: High first-pass metabolism extensively reduces oral bioavailability. Parenteral routes (IV,
IM, SQ) or routes that largely avoid portal circulation (e.g., sublingual, transdermal) circumvent first-
pass hepatic metabolism.
Question 3. The volume of distribution (Vd) of a drug is best described as:
A. The apparent volume into which the drug is distributed, calculated as amount of drug in body
divided by plasma concentration
B. The actual anatomic volume of plasma only
C. The rate of renal clearance
D. The fraction of drug bound to plasma proteins
Correct Answer: A
Rationale: Vd = Amount of drug in body / Plasma concentration. It is a theoretical volume that
indicates the extent of tissue distribution; a large Vd implies extensive tissue binding.
NR 565 Advanced Pharmacology Fundamentals Final Comprehensive Examination 2026/2027 | Verified Questions
, Question 4. Which pharmacokinetic parameter is most useful for determining the dosing
interval of a drug?
A. Volume of distribution alone
B. Elimination half-life (t½)
C. Bioavailability only
D. Protein-binding percentage
Correct Answer: B
Rationale: Half-life determines how quickly plasma concentration declines and therefore guides dosing
frequency. Drugs with short half-lives generally require more frequent dosing or continuous infusion.
Question 5. A drug that is a strong CYP3A4 inducer will most likely have which effect on a
co-administered CYP3A4 substrate?
A. Increase the plasma concentration of the substrate
B. Have no effect on the substrate
C. Decrease the plasma concentration of the substrate, potentially reducing its efficacy
D. Only affect renal excretion of the substrate
Correct Answer: C
Rationale: CYP inducers increase the synthesis of metabolizing enzymes, accelerating clearance of
substrates and lowering their plasma levels. Dose adjustments or alternative agents may be required.
Question 6. Zero-order elimination kinetics means that:
A. A constant amount of drug is eliminated per unit time, independent of plasma concentration
B. A constant fraction of drug is eliminated per unit time
C. Elimination rate increases linearly with concentration
D. The drug is eliminated only by the kidneys
Correct Answer: A
Rationale: In zero-order kinetics (e.g., high-dose phenytoin, ethanol), elimination pathways are
saturated, so a fixed amount is removed per time. Most drugs at therapeutic doses follow first-order
kinetics.
Question 7. Which statement about protein binding is correct?
A. Bound drug is the only active form
B. Protein binding increases the free fraction
C. Highly protein-bound drugs are always short-acting
D. Only the unbound (free) fraction of a drug is pharmacologically active and available for metabolism
and excretion
Correct Answer: D
Rationale: The free fraction interacts with receptors and is subject to clearance. Highly protein-bound
drugs can be displaced by other highly bound drugs, transiently increasing free concentration.
Question 8. Bioavailability (F) of an orally administered drug is defined as:
A. The total amount of drug excreted in urine
B. The rate of absorption only
C. The fraction of the administered dose that reaches the systemic circulation unchanged
D. The volume of distribution
Correct Answer: C
Rationale: Bioavailability accounts for both the extent of absorption and the degree of first-pass
metabolism. IV administration is defined as having F = 1.
NR 565 Advanced Pharmacology Fundamentals Final Comprehensive Examination 2026/2027 | Verified Questions
